The local bourse has been busy again these past two weeks. These movements offer a fascinating, albeit partial, glimpse into the perspectives of company insiders and significant investors.

On the directorial front, at Ascendis Health there was a show of confidence from within as associates of CEO Carl Neethling and director Theunis de Bruyn executed on-market purchases of 179,264 ordinary shares on April 14 for 80c a share. Neethling’s transaction was made through ACN Capital, where he is the controlling shareholder, while De Bruyn’s was made via Calibre Investment Holdings, where he is a director and shareholder. Ascendis posted rosier results recently, so the purchases appear well timed...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.